Down More Than 18% in 3 Months, Is STAAR Surgical Still A Buy?
Sometimes, great businesses can have poorly performing stocks. On that note, STAAR Surgical (NASDAQ: STAA) is one of my favorite healthcare companies, but alas, its shares have fallen choppily in the last three months. And, even amid its ongoing success in the implantable lens market, my suspicion is that there are at least a few more storm clouds on the horizon.
It's too soon to call the recent decline a collapse, but it's understandable that investors are concerned. There's more than one issue at play here, so let's dive in and analyze the situation to see if the stock is still worth adding to your portfolio.
Image source: Getty Images.
Source Fool.com
